Efficacy and safety of pembrolizumab in Chinese patients with recurrent/unresectable/metastatic head and neck squamous cell carcinoma.

被引：0
|
作者：
Li, Jieying [1 ]
Song, Kai [1 ]
Feng, Yuanyong [1 ]
Shang, Wei [1 ]
机构：
[1] Univ Affiliat Hosp Qingda, Affiliated Hosp Qingdao, Qingdao, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18001
引用
收藏
页码：E18001 / E18001
页数：1
相关论文
共 50 条
  • [1] Pembrolizumab and afatinib for recurrent or metastatic head and neck squamous cell carcinoma
    Kao, H-F.
    Hong, R-L.
    ANNALS OF ONCOLOGY, 2018, 29 : 379 - 379
  • [2] Pembrolizumab and afatinib for recurrent or metastatic head and neck squamous cell carcinoma
    Kao, Hsiang-Fong
    Huang, Huai-Cheng
    Liao, Bin-Chi
    Hong, Ruey-Long
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [3] Efficacy and safety of apatinib as second-line or beyond therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.
    Qin, You
    Ding, Qian
    Xu, Xinhua
    Cao, Fengjun
    Ning, Siqing
    Zhou, Haibo
    Chen, Guiming
    Huang, Jing
    Peng, Gang
    Yang, Kunyu
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [4] A multicenter, retrospective study analysis: Evaluating the efficacy and safety of pembrolizumab in the first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma.
    Hu, Man
    Zhang, Shichuan
    Han, Yaqian
    Wu, Hui
    Gao, Jin
    Wu, Haijun
    Lin, Qin
    Shang, Wei
    Li, Xia
    Feng, Hong
    Qiao, Qiao
    Hu, Guangyuan
    Yang, Kunyu
    Song, Xicheng
    Cao, Yuandong
    Kang, Min
    Wang, Ruozheng
    Yu, Jinming
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [5] Pembrolizumab for recurrent/metastatic head and neck squamous cell carcinoma in an Asian population
    Chen, Wen-Chun
    Chu, Pen-Yuan
    Lee, Yu-Ting
    Lu, Wen-Bin
    Liu, Chun-Yu
    Chang, Peter Mu-Hsin
    Yang, Muh-Hwa
    MEDICINE, 2017, 96 (52)
  • [6] Efficacy and safety of cisplatin and weekly docetaxel in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
    Kim, Moon Jin
    Kim, Sung Min
    Jung, Hyun Ae
    Hong, Jung Yong
    Chang, Won Jin
    Choi, Moon Ki
    Kim, Hye Soak
    Sun, Jong-Mu
    Park, Keunchil
    Ahn, Myung-Ju
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2019, 34 (05): : 1107 - 1115
  • [7] Efficacy and safety of vinorelbine in heavily pretreated recurrent/metastatic head and neck squamous cell carcinoma patients
    Barth, Claire
    Naveau, Louise
    Touboul, Emmanuel
    Perie, Sophie
    Bamogho, Edith
    Haberer-Guillerm, Sophie
    Schlienger, Michel
    St Guily, Jean Lacau
    Huguet, Florence
    ANTI-CANCER DRUGS, 2016, 27 (04) : 349 - 352
  • [8] Efficacy of Nivolumab and Pembrolizumab in Platinum-sensitive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
    Yamashita, G. A., I
    Okamoto, I. S. A. K. U.
    Ito, T. A. T. S. U. Y. A.
    Tokashiki, K. U. N. I. H. I. K. O.
    Okada, T. A. K. U. R. O.
    Tsukahara, K. I. Y. O. A. K. I.
    ANTICANCER RESEARCH, 2023, 43 (08) : 3679 - 3683
  • [9] Simlukafusp a and cetuximab combination in patients with recurrent, unresectable or metastatic squamous cell carcinoma of the head and neck
    Hansen, A. R.
    Gomez-Roca, C. A.
    Lolkema, M. P.
    Verlingue, L.
    Italiano, A.
    Spicer, J.
    Steeghs, N.
    Bauman, J. E.
    Fayette, J.
    Niu, J.
    Prenen, H.
    Dejardin, D.
    Boetsch, C.
    Kraxner, A.
    Evers, S.
    Vardar, T.
    Keshelava, N.
    Teichgraber, V.
    Bonomi, M.
    ANNALS OF ONCOLOGY, 2021, 32 : S805 - S805
  • [10] Safety evaluation of pembrolizumab for treating recurrent head and neck squamous cell carcinoma
    Desilets, Antoine
    Soulieres, Denis
    EXPERT OPINION ON DRUG SAFETY, 2020, 19 (08) : 927 - 933
12345